Texas COPD Patient Dies by Suicide After Insurance Confusion Delays Critical Medication

Key points

• Kenney Blewett, diagnosed with COPD over a decade ago, experienced severe flare-ups in 2026 that left him unable to breathe and caused significant weight loss.
• On June 2, 2026, his pulmonologist prescribed a new inhaled liquid medication, but Walgreens reported an 'insurance issue' delaying the fill two days later.
• Cindy Blewett struggled to determine which of her husband's multiple insurance policies (Medicare Part B, Part D, and Medigap) was responsible for the delay.
• Walgreens later claimed the prescription was submitted to Medicare Part B but lacked a necessary diagnostic code, while the pulmonologist's office denied receiving a request for that code.
• Kenney died by suicide on June 7, 2026, leaving a note stating his health was too poor to continue living; a second medication ordered directly from the manufacturer arrived weeks after his death.
• Nearly 70% of adults in a January KFF poll called insurance delays a 'major problem,' despite a voluntary 2025 industry pledge to improve access that carries no penalties for non-compliance.

Background

This incident occurs amid growing concerns over the complexity of Medicare and the rise of artificial intelligence in prior authorization processes. In January 2026, Medicare launched a pilot program in six states, including Texas, using AI to preapprove services, which critics argue creates more red tape. Additionally, a July 2026 report found that some insurers signing a voluntary pledge to reduce barriers failed to implement promised initiatives. The case underscores the confusion surrounding the distinction between Medicare Part B and Part D coverage for durable medical equipment versus drugs, a complexity that often confuses even medical staff and pharmacy employees.

Why it matters

The death of Kenney Blewett illustrates the life-threatening consequences of bureaucratic hurdles in healthcare. As insurance systems become more complex and AI-driven, patients face increased risks of delayed or denied care. The lack of federal accountability for voluntary industry pledges and the confusion over Medicare coverage categories leave vulnerable populations, such as elderly COPD patients, without adequate protection or recourse when critical treatments are withheld.

What to watch

Cindy Blewett continues to seek answers from Medicare, her husband's private Part D plan, his pulmonologist, and Walgreens, but has not received clear explanations for the delay. Industry experts expect the scope of Medicare's AI pilot program to expand to more services and states, potentially increasing the complexity of prior authorization for patients. Without substantial federal reform or state-level jurisdiction over most insurance plans, patients may face even greater challenges navigating insurance hurdles in the future.